Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Pervasive chromothripsis drives pleural mesothelioma to impact gene function and patient survival

Pleural mesothelioma (PM) is a tumour type showing high structural complexity but the full spectrum of variants present and their impacts are poorly understood. We comprehensively describe the mutational landscape of mesothelioma, exploiting a large (N=443) cohort profiling the tumour genome and transcriptome in parallel. We find that the majority of candidate driver variants are mediated by copy…

Pleural mesothelioma (PM) is a complex tumor type, and researchers have now mapped out its genetic landscape using a large cohort of 443 patients. The study reveals that most genetic alterations in PM are caused by copy number alterations (CNAs), and a significant number of tumors exhibit complex rearrangements. The most common of these are chromothripsis (74% of cases) and chromoplexy (59%).

Chromothripsis, a catastrophic event in which a chromosome undergoes multiple breaks and rearrangements in a single event, plays a critical role in driving genetic changes in PM. This process leads to the deletion of known tumor suppressor genes, including CDKN2A, NF2, and BAP1. These genes are believed to be among the earliest events in the development of PM. Furthermore, the presence of chromothripsis in PM tumors is associated with significantly poorer patient survival rates.

The study also uncovers a complex interplay between the mitochondrial and nuclear genomes during the evolution of PM. This involves alterations to both genomes, as well as changes in mitochondrial expression levels. These findings shed light on the multifaceted nature of PM, highlighting the importance of considering both the nuclear and mitochondrial genomes in understanding this devastating disease.

Written by urgent.news from bioRxiv's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at biorxiv.org →

More in Health & Medicine

This implant can restore sight for patients with macular degeneration

시력을 되돌리는 임플란트 승인 뉴스에서 시작해, 양안시 훈련의 도구를 다시 생각하다 안녕하세요, Seven Sportz 팀입니다. 이번 주에 눈에 띈 뉴스 하나로 시작하겠습니다. MIT Technology Review는 지도성 위축(geographic atrophy) 형태의 황반변성 환자에게 시각을 되돌려주는 이식형 시스템 PRIMA를 보도했습니다.

More from Wednesday 4 November →